Investor Presentaiton
Médica Sur, S.A.B. and Subsidiaries
STATEMENT CONSOLIDATED RESULTS AND OTHER COMPREHENSIVE RESULTS
Years ending on December 31, 2016 and 2015
(Mexican pesos)
Service revenue
Service costs
Consolidated gross profit
Notes
2016
2015
$
2,590,272,612 2,278,751,602
1,794,333,517 1,569,274,825
795,939,095 709,476,777
Médica Sur, S.A.B. and Subsidiaries
CONSOLIDATED STATEMENT OF CASH FLOWS
Years ending on December 31, 2016 and 2015
(Mexican pesos)
Cash flows from operating activities:
Total pre-tax profit
Adjustments for:
Net cost of the period for employee benefits
Notes
2016
2015
$ 199,730,800 349,579,120
Expenses:
Sales and administrative expenses
Other (income) expenses, net
24
588,202,883 358,818,301
(2,922,504) 19,615,186
Total expenses
585,280,379 378,433,487
Consolidated operating income
210,658,716 331,043,290
Financial income and costs
Foreign currency gain, net
15,031,944
7,873,078
Participation in the results of affiliated companies
15
(4,077,369)
Impairment of investment in affiliated company shares
15 y 24
10,401,840
Depreciation and amortization
13 y 14
Losses in the sale of transportation equipment and other assets
Interest income
325,247,154
107,917
121,748,868
(15,110,169)
193,823
(10,910,475)
Interest expenses
Interest income
839,523
(26,877,608)
15,110,169
3,627,898
10,910,475
(Costs) Financial income, net
25
(10,927,916)
14,458,461
Participation in the results of affiliated companies
15
Consolidated operating income before tax
199,730,800
349,579,120
Profit tax
19
53,519,878
108,461,781
Consolidated operating income
$ 146,210,922
241,117,339
Other comprehensive results
Net actuarial profits (losses) from
income tax
18
Consolidated comprehensive income
$
Net comprehensive income attributable to:
Controlling interests
$
Non-controlling interests
142,634,010 241,018,529
3,576,912
98,810
$
146,210,922
241,117,339
(79,912)
4,077,369
1,936,970
(306,550)
148,147,892 240,810,789
Entries from financing activities:
Interest expenses
Subtotal
Accounts receivable, net
Médica Sur Clinical Foundation, A. C.
Other accounts receivable
Inventories, net
Prepaid insurance
Suppliers
Taxes and accrued expenses
Provisions for contingent liabilities
Net cash flows from operating activities
Paid taxes
Interest paid
Net flows generated from operating activities
Investment activities:
Increase (decrease) in other non-current assets, net
Interest collected
26,877,608
79,912
551,885,254 474,888,797
(4,108,574) (4,277,881)
95,606
(115,305)
(42,821,646)
1,943,706
(24,208,083)
(9,102,220)
(10,172,043)
(737,095)
(204,087,506)
(29,803,571)
80,594,487
26,664,296
15,436,374
1,800,000
362,613,869 461,260,727
(143,192,000) (133,373,575)
(20,639,728)
(79,912)
198,782,141 327,807,240
4,837,391
15,110,169
Revenue from the sale of properties, furnishings and equipment
Acquisitions of property, furnishings, equipment and investment properties
Dividends received from investments in affiliated companies
Business acquisitions
13 y 14
(2,073,299)
10,910,475
767,963
(230,325,263) (228,355,320)
6,527,202
6
Net cash flows used in investment activities
Financing activities
(1,447,493,000)
(1,657,870,703) (212,222,979)
Consolidated comprehensive income attributable to:
Loans obtained
Controlling interests
$
Non-controlling interests
144,570,980
3,576,912
240,711,979
Dividends paid
98,810
Net cash flows generated by (used in) financing activities
SA
$
148,147,892
240,810,789
Basic and diluted earnings per share
Weighted average number of shares
$
1.19
1.95
Cash and cash equivalents:
22
123,281,750
123,281,750
Net decrease (increase) in cash and cash equivalents
At the beginning of the year
At the end of the year
17
1,285,000,000
21
(80,729,079) (100,632,547)
1,204,270,921 (100,632,547)
(254,817,641) 14,951,714
9 $
359,127,708 344,175,994
104,310,067 359,127,708
See the relevant notes to the Consolidated Financial Statements.
36
16 // ANNUAL REPORT
See the relevant notes to the Consolidated Financial Statements.
3 7View entire presentation